These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 18460263)

  • 1. Osteonecrosis of the jaw.
    Sambrook PN; Ebeling P
    Curr Rheumatol Rep; 2008 Apr; 10(2):97-101. PubMed ID: 18460263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis.
    Rizzoli R; Burlet N; Cahall D; Delmas PD; Eriksen EF; Felsenberg D; Grbic J; Jontell M; Landesberg R; Laslop A; Wollenhaupt M; Papapoulos S; Sezer O; Sprafka M; Reginster JY
    Bone; 2008 May; 42(5):841-7. PubMed ID: 18314405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate medications and your oral health.
    J Am Dent Assoc; 2006 Jul; 137(7):1048. PubMed ID: 16803833
    [No Abstract]   [Full Text] [Related]  

  • 4. A physician discusses the dental impact of oral bisphosphonates.
    Roudebush CP
    J Indiana Dent Assoc; 2006-2007 Winter; 85(4):4-5. PubMed ID: 17489111
    [No Abstract]   [Full Text] [Related]  

  • 5. Bisphosphonates, osteonecrosis of the jaw, and dental treatment recommendations.
    Radfar L; Masood F
    J Okla Dent Assoc; 2008; 99(7):28-9. PubMed ID: 18595621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteonecrosis of the jaw due to bisphosphonates.
    Prescrire Int; 2008 Oct; 17(97):202-3. PubMed ID: 19536938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus practice guidelines for bisphosphonate-associated osteonecrosis of the jaw.
    Sambrook PN
    Nat Clin Pract Rheumatol; 2009 Jan; 5(1):6-7. PubMed ID: 19030005
    [No Abstract]   [Full Text] [Related]  

  • 8. Osteonecrosis of the jaw and bisphosphonates--putting the risk in perspective.
    Bolland M; Hay D; Grey A; Reid I; Cundy T
    N Z Med J; 2006 Dec; 119(1246):U2339. PubMed ID: 17151713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complication related to bisphosphonate therapy: osteonecrosis of the jaw.
    Lee J
    J Infus Nurs; 2009; 32(6):330-5. PubMed ID: 19918142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate therapy and dental treatment.
    Phillips G
    J Mich Dent Assoc; 2009 Aug; 91(8):40, 42-5. PubMed ID: 19722373
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent recommendations on bisphosphonate-associated osteonecrosis of the jaw.
    Arrain Y; Masud T
    Dent Update; 2008 May; 35(4):238-40, 242. PubMed ID: 18557500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteonecrosis of the jaw in older osteoporosis patients treated with intravenous bisphosphonates.
    Baillargeon J; Kuo YF; Lin YL; Wilkinson GS; Goodwin JS
    Ann Pharmacother; 2011 Oct; 45(10):1199-206. PubMed ID: 21954448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate use in conditions other than osteoporosis.
    Silverman SL
    Ann N Y Acad Sci; 2011 Feb; 1218():33-7. PubMed ID: 20946575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of bisphosphonate use for the dentist: an introduction.
    Kurtzman GM; Silverstein LH; Peden J; Shatz PC
    Dent Today; 2006 Jun; 25(6):80, 82-5; quiz 85. PubMed ID: 16792113
    [No Abstract]   [Full Text] [Related]  

  • 15. Bisphosphonates and osteonecrosis of the jaw.
    Sambrook P; Olver I; Goss A
    Aust Fam Physician; 2006 Oct; 35(10):801-3. PubMed ID: 17019456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
    Marx RE; Sawatari Y; Fortin M; Broumand V
    J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Osteonecrosis of the jaw].
    Drozdzowska B
    Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tooth extraction: Is it inciting event or sequela of osteonecrosis of the jaws associated with intravenous bisphosphonates?
    Altundag K; Bulut N; Tezcan E; Ozen M; Purnak T
    J Oral Maxillofac Surg; 2007 Jan; 65(1):154. PubMed ID: 17174785
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bisphosphonate-associated osteonecrosis of the jaw in rheumatology: a systematic review].
    Capsoni F
    Reumatismo; 2008; 60(1):6-13. PubMed ID: 18432320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.